Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

clearside biomedical

POPULAR ARTICLES

Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE

Clearside Biomedical Submits New Drug Application for XIPERE for the Treatment of Macular Edema Associated with Uveitis

Pharmaceutical Investing

Clearside Biomedical Announces Fourth Quarter 2017 Financial Results and Provides Corporate Update

LATEST ARTICLES

Pharmaceutical Investing

Clearside Announces Pricing of Public Offering of Common Stock

Pharmaceutical Investing

Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA

Pharmaceutical Investing

Clearside Biomedical Completes Enrollment for Phase 1/2 Trial

Pharmaceutical Investing

Clearside Biomedical Announces First Patient Randomized in Phase 3 Clinical Trial of Zuprata™ Used Together With Eylea in Subjects With Retinal Vein Occlusion

Clearside Biomedical Announces Pricing of Public Offering of Common Stock

Clearside Biomedical Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Zuprata™

Latest News

Ni-Co Energy: Advancing a Strategic Nickel-Copper-Cobalt Project in Quebec

Blue Lagoon Resources: Summer 2025 Production-ready Gold Producer in British Columbia

Ramp Metals Provides Drill and Geophysics Update

Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor

Osisko Metals Intersects 300 Metres Averaging 0.39% Copper at Gaspé Copper Project